Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics.

  • Jürgen B Bulitta
  • , Yuanyuan Jiao
  • , Cornelia B Landersdorfer
  • , Dhruvitkumar S Sutaria
  • , Xun Tao
  • , Eunjeong Shin
  • , Rainer Höhl (Co-author)
  • , Ulrike Holzgrabe
  • , Ulrich Stephan
  • , Fritz Sörgel

Research output: Contribution to journalOriginal Articlepeer-review

5 Citations (Web of Science)
Original languageEnglish
JournalPHARMACEUTICS
Volume11
Issue number7
DOIs
Publication statusPublished - 2019

Keywords

  • PHARMACODYNAMIC BREAKPOINTS
  • INTESTINAL ELIMINATION
  • ORAL BIOAVAILABILITY
  • GYRASE INHIBITORS
  • P-GLYCOPROTEIN
  • CIPROFLOXACIN
  • SECRETION
  • INVOLVEMENT
  • MECHANISM
  • PATHWAYS

Cite this